Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Down Syndrome-Associated Alzheimer's Disease (DS-AD)”

2 trials

Showing 2 of 2 results

Testing effectiveness (Phase 2)Looking for participantsNCT07636811
What this trial is testing

Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)

Who this might be right for
Down Syndrome-Associated Alzheimer's Disease (DS-AD)
Alnylam Pharmaceuticals 58
Not applicableStudy completedNCT06484426
What this trial is testing

Goal Attainment Scaling (GAS) Sub-Study

Who this might be right for
Alzheimer's Disease in Down Syndrome
LuMind IDSC Foundation 46

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation